Alnylam Pharma (ALNY) Tops Q3 EPS by $2.38
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mail
Get Alerts ALNY Hot Sheet
Price: $165.00 -5.17%
Financial Fact:
General and administrative: 17.99M
Today's EPS Names:
SYRS, ZVOI, OMID, More
Financial Fact:
General and administrative: 17.99M
Today's EPS Names:
SYRS, ZVOI, OMID, More
Join SI Premium – FREE
Alnylam Pharma (NASDAQ: ALNY) reported Q3 EPS of $2.90, $2.38 better than the analyst estimate of $0.52. Revenue for the quarter came in at $1.25 billion versus the consensus estimate of $946.73 million.
For earnings history and earnings-related data on Alnylam Pharma (ALNY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Texas Capital Securities Downgrades Full House Resorts (FLL) to Hold
- CBOE Holdings (CBOE) PT Raised to $357 at Wells Fargo
- Citi cuts TFI International price target to $123 after earnings miss
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
